ABSTRACT
INTRODUCTION
It's a well-established fact that bacterial plaque is the prime causative agent for periodontal diseases. 1, 2 Microbial cultures and analysis shows a marked difference in composition of subgingival plaque when healthy and diseased are compared. [3] [4] [5] [6] The predominance of Gram-negative anaerobic bacterial rods in the subgingival plaque in periodontal diseases has been well documented. 7, 8 Recent periodontal therapies are more directed towards the use of antibiotics targeted against the specific microorganisms. 9, 10 With the use of systemic antibiotics in the treatment, came the major disadvantages like the risk of development of its systemic side effects and bacterial resistance. 7, 11, 12 Thus, to overcome the shortcomings of systemic drug delivery system, attention was recently focussed on local drug delivery systems for administration of antibiotics under therapeutic levels directly into the periodontal pocket. With the incoming of this local drug delivery system, its popularity increased, and several drugs were successfully used for the treatment of periodontal diseases with this method with encouraging results.
Various studies of pharmacokinetics on doxycycline showed that this drug has achieved higher levels in the gingival fluid than in blood. [13] [14] [15] Systemically doxycycline has shown to be effective against Porphyromonas gingivalis, Bacteroides intermedius and Fusobacterium nucleatum in periodontitis with a long-lasting substantivity on periodontally diseased root surfaces. 16, 17 Thus, the purpose of the present study was to evaluate the effect of subgingival placement of doxycycline in the form of a resorbable membrane on the clinical and microbiological parameters in the treatment of inflammatory periodontal disease for 10 weeks.
MATERIALS AND METHODS
The present study evaluates the effects of a controlled release system containing doxycycline both in vivo and in vitro conditions.
In Vitro Preparation of Drug Release System
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One gm of hydroxypropyl methylcellulose powder dissolved in 19.75 mL of distilled water at 700 o C. The solution was then cooled to 250 o C and then 500 mg doxycycline hydrochloride powder was added and centrifuged for 3 minutes to achieve a uniform distribution of the drug. The solution was kept at 300 o C for three days to obtain sheets of 0.15 mm thickness. The entire procedure was carried out in a clear air workstation to maintain absolute sterile conditions.
Determination of Doxycycline Release Rate
Films of 1 cm x 1 cm were cut and weighed accurately. Five doxycycline and one control (plain hydroxypropyl methylcellulose) strips were then placed in 5 beakers containing 50 mL of double distilled water at ph 6.6 (simulated gingival crevicular fluid) respectively. The beakers were placed in an orbital shaker connected to a water bath at 37 o C and rotating at 100 rpm. 0.5 mL of fluid was then pipped out from each of the beakers with a micropipette, immediately on placing on each of the doxycycline and control strips into the beakers respectively. The similar procedures were then carried after 1 hour and 6 hours on day 1. Then 0.5 mL of this fluid was added to the test tube containing 2.5 mL of distilled water to make a total of 3 mL of fluid. This 0.5 mL of fluid removed was then replaced in each beaker by an equivalent amount of distilled water (Fig. 1) . The similar procedure was repeated similarly for next seven days. The fluid thus obtained from all five beakers was subjected to spectrophotometer analysis using the measurement of absorption at 360 nm at 1 hour and 6 hours intervals on all the 6 days. The amount of doxycycline in one strip was calculated as (1) weight of one drug strip 0.048 g, (2) weight of 1 plain placebo strip 0.019 g, and (3) weight of doxycycline in 1 plain placebo strip 0.029 g.
In Vivo Drug System
A total of nineteen patients, both male, and females suffering from inflammatory periodontal disease attending the department were included in the study. The age ranged from 35 to 50 years. The inclusion criteria included those patients only who were free from any systemic and hormonal disturbances. Also known patients of hypersensitivity were excluded from the study. All the study patients were advised to continue their routine oral hygiene methods.
For this study, specific teeth, i.e., mandibular first and second molar were chosen. The selected teeth had a pocket depth greater than 5 mm, were free from any prosthesis, restorations or caries. It was made sure that the experimental and control teeth were in separate quadrants to minimize the potential for interaction between treatments. Before baseline measurements, all subjects underwent supragingival scaling to eliminate effects of therapy on gingivitis. A week later baseline clinical measurements and microbial samples were taken from each of two test sites. For clinical measurements, every week follow up was done for a total of 10 weeks whereas microbial sampling was done at 1st, 3rd, 7th and 9th-week intervals. 
Radiographic Examination
Each radiographic site was assessed radiographically for the amount of bone left, and Russell's periodontal index was recorded for every selected tooth.
Clinical Examination
Gingival index was scored according to Loe and Silness (1964) criteria, Probing depth was calculated using Hu-Friedy (PCP-UNC-15) probe with calibrated probe length of 15 mm and tip diameter of 0.45 mm, and for Attachment levels a fixed reference point was made on the selected tooth from which loss or gain of attachment teeth was calculated. Gingival shrinkage was also recorded.
Methodology of Treatment
Placement of Controlled Drug Delivery Device
Each patient had two test sites, one mandibular molar as an experimental site and other quadrant mandibular molar as control. The test site was subjected to the subgingival placement of doxycycline resorbable membranes in the form of strips, using tweezers ( Fig. 2A) . Whereas, the control site received the resorbable membrane containing plain hydroxypropyl methylcellulose (Fig. 2B) .A minimum of two strips was inserted into each periodontal pocket with its long axis parallel to the tooth. The patients were recalled once a week and the strips were placed every week for a period of 8 weeks.
Sample Collection for Microbial Analysis
The areas to be sampled were isolated and dried to avoid saliva contamination. The subgingival plaque samples were collected from each patient with a paper point inserted into the depth of the periodontal pocket for 10 seconds (Fig. 3) . The samples were then suspended into 5 ml of sterile test tubes containing double sterile distilled water and shaken vigorously. The test tubes were transported to the laboratory by placing them in an ice pail where they were inoculated in 5 ml of thioglycolate liquid media. Later 1000 µL of sample is pipetted and diluted eight times. The last five dilutions were again inoculated in thioglycolate containing test tubes and incubated for 48 hours at 37 o C under anaerobic conditions. Those test tubes which showed yellow turbidity were counted for the calculation of approximate number of anaerobic bacteria present (Fig. 4) . 
Statistical Analysis
All the observations were recorded and tabulated and sent for statistical analysis. Means and standard deviations were calculated for each group. For mutual significance between each group student 't' test was used. A correlation coefficient was also used to study the multi variable correlations.
RESULTS
With a total of 19 patients included in the study, the results of the in-vitro study showed that the doxycycline hydroxypropyl methylcellulose films are capable of releasing the drug in a sustained way with respect to time ( Table 1) . Maximum release of the drug was observed in 1st hour (43.80 µg) with a tapered decrease of 13.5 µg at end of 1st day, 8 µg between 3 to 4 days and 2 µg between 2 to 6 days.
From the results of the vivo study mean values of the gingival index, probing depth and gingival shrinkage observed were recorded ( Table 2) .
It was observed that throughout the study the gingival index score showed low levels at the doxycycline-treated sites. In all the weeks of visit except between zero and the 1st week there was a statistically significant difference between placebo and doxycycline group. By the end of the study, sites treated by doxycycline were clinically healthy (GI = 0) and bleeding on probing was markedly decreased. However, the controlled sites continued to show bleeding on probing by the end of the study.
The probing depth measurements also showed a significant improvement at the end of 10 weeks study period at the doxycycline-treated sites with no obvious change in the probing depth at the control placebo sites. Albeit no statistically significant difference was observed between placebo and doxycycline groups from baseline and 5th week.
With the insertion of doxycycline containing controlled release device, a significant gingival shrinkage of almost 2 mm was observed by the end of the study as compared to the baseline. Whereas no significant difference was observed in the control group. A little gain of attachment levels was observed after 30 days and between 30 days and 60 days in the experimental group. Whereas no significant difference was observed between the control group and the experimental group.
The microbial culture results showed a marked reduction in the total anaerobic count post-treatment and till the end of the 10-week study period in the doxycyclinetreated group. Whereas, no significant change was observed in the control group. By first week no statistically significant difference was observed between the two study groups but later from 3rd to 9th week, there existed a statistically significant difference of 0.1% levels. The correlation coefficient values revealed that the clinical and microbial parameters are positively correlated with each other in the doxycycline group and for the placebo group for all 5 weeks (Tables 3 and 4) . Thus, overall results showed that 30% doxycycline methylcellulose strips have significant effects and benefits on clinical and microbial parameters in more than 5 mm deep periodontal pockets (Figs 5A to D) .
DISCUSSION
In the recent years, various attempts have been made to control periodontal diseases by targeting the subgingival plaque. Many bacterial studies have been done using various systemic antibiotics against subgingival plaque.
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Local drug delivery system, is one of such commonly used practices in recent times, using various materials as carrier substances. 21 These devices are popular as they have shown to exhibit best results with a minimum dosage of the substance used. Therefore, various such controlled release devices are established and evaluated for both bacteriological and clinical efficacy in terms of their degree of controlled drug release, their therapeutic effects and the duration of their effect after administration. Both resorbable and non-resorbable base materials have been used to allow antibiotics and antibacterial drugs to stay in the periodontal pocket for a long period. Resorbable polymers may be preferable as a base material because of their ability to dissolve and be resorbed in the periodontal pocket after a certain period, thus avoiding damage to the regenerating tissues at the treated site.
In the present study, we also used resorbable hydroxypropyl methylcellulose as a carrier to provide prolonged release of doxycycline. This formulation is biodegradable; hence a second dental visit was not necessary to remove the material from the gingival crevice. This is a significant advantage in the clinical use of doxycycline formulation for both the therapist and the patient. Thus, In the present study, we evaluated doxycycline strips were clinically and bacteriologically evaluated to access their clinical effectiveness.
The results of the present study showed a marked improvement in the periodontal health produced using doxycycline membrane strips. Our results were consistence with the findings of Sachdeva S et al. 22 and Addy et al. 20 The optimum admixture of the drug in the polymer has resulted in the maximum amount of the drug being released within the first one or two hours, in the vitro study. This is because of the polymer matrix becoming more porous permitting the release of the water-soluble drug.
Another important finding of the present study relates to the reduction in the rate at which doxycycline gets released with the passage of time. This finding is in accordance with the in vitro studies conducted by Tsalikis et al., 23 Stabholz 24 and Ahamed S et al. 25 Hence it was confirmed that the kinetics of doxycycline release in vivo is diffusion controlled. In this system, the release rate of the drug from the polymer membrane was controlled by the combination of the drug, surface area, solubility in the polymer and the polymer system. In the present study, significant changes were observed in the clinical parameters. These results were seen for each of the key clinical parameters used to evaluate periodontitis such as probing depth and gingival shrinkage. There was a significant decrease in the probing depth along with mitigation of inflammation. The subsiding of gingival inflammation was probably responsible for the lowest value of probing depth obtained at the end of the experimental period. However, the significant gain in attachment levels contributing to the reduced probing depth could not be observed at the end of 10th week study period.
The incidence of bleeding on probing was significantly reduced using doxycycline films, as compared to the control group. Greensteen 26 also reported that use of bleeding as an index is widely accepted, which reflects disease activity. The statistically significant reduction in probing depth and gingival shrinkage when compared to the baseline correlated with each other suggesting that the resolution of gingival inflammation due to edema was largely responsible for the reduction in probing depth.
Also, in the present study, a significant decrease in the total anaerobic count was observed at the end of the experimental study. Thus, suggesting that the controlled subgingival doxycycline release aids in the reduction of the pathogenic microbial flora, by effectively altering bacterial composition of the periodontal pocket. The benefits of this therapy were maintained for 2 weeks both in the clinical and microbiological parameters. To simplify it can be said that the insertion of doxycycline release devices once a week for 8 weeks resulted in remarkable improvement both clinically and microbiologically. Thus, it was seen that overall a controlled delivery system produces a significant increase in local concentration of the drug as compared to the systemically administered one.
Lastly, it was observed that overall a significant positive correlation was found between the clinical and microbiological parameters in both the doxycycline and placebo groups in this study of ours. This proved that both these parameters were closely related and interdependent.
Data from literature (Feres et al. 27 , Xajigeorgiou et al. 28 ) reveals that there are conflicting outcomes of different studies investigating the effect of doxycycline on microbiological parameters of periodontal disease.
The clinical significance of this study lies in that such drug delivery systems have greater benefits and more targeted effects as compared to the systemic ones. Doxycycline has proven to have great promise as an antibiotic of choice. Thus, there is a significant advantage in the clinical use of doxycycline formulation for both the therapist and the patient. It can be said that we need to extend these studies to evaluate the effectiveness of these devices on specific periodontal pathogens, as well as to evaluate their long-term clinical effects.
CONCLUSION
Through this study, we can conclude that 30% doxycycline both in vivo and vitro study has proven to be an effective antibiotic of choice both clinically and microbiologically. There was a significant decrease in clinical parameters observed by the end of 8th week, and the effects were maintained till 2 weeks, even the microbiological parameters significantly improved by the end of 10th week with the marked decrease in anaerobic count.
